25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Biotron Ltd
Buy, Hold or Sell?

Let's analyze Biotron together

I guess you are interested in Biotron Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Biotron Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Biotron Ltd

I send you an email if I find something interesting about Biotron Ltd.

1. Quick Overview

1.1. Quick analysis of Biotron (30 sec.)










1.2. What can you expect buying and holding a share of Biotron? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
20.0%

What is your share worth?

Current worth
A$0.00
Expected worth in 1 year
A$-0.02
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
A$-0.02
Return On Investment
-79.7%

For what price can you sell your share?

Current Price per Share
A$0.02
Expected price per share
A$0.018 - A$0.024
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Biotron (5 min.)




Live pricePrice per Share (EOD)
A$0.02
Intrinsic Value Per Share
A$-0.04 - A$-0.03
Total Value Per Share
A$-0.04 - A$-0.03

2.2. Growth of Biotron (5 min.)




Is Biotron growing?

Current yearPrevious yearGrowGrow %
How rich?-$163.1k$2.1m-$2.2m-1,400.1%

How much money is Biotron making?

Current yearPrevious yearGrowGrow %
Making money-$2.2m-$2.3m$37.5k1.6%
Net Profit Margin0.0%-244.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Biotron (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Biotron?

Welcome investor! Biotron's management wants to use your money to grow the business. In return you get a share of Biotron.

First you should know what it really means to hold a share of Biotron. And how you can make/lose money.

Speculation

The Price per Share of Biotron is A$0.019. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biotron.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biotron, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.00. Based on the TTM, the Book Value Change Per Share is A$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biotron.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-13.4%0.00-13.4%0.00-13.6%0.00-12.9%0.00-11.1%
Usd Book Value Change Per Share0.00-13.3%0.00-13.3%0.008.1%0.00-4.4%0.00-0.6%
Usd Dividend Per Share0.000.0%0.000.0%0.0019.9%0.007.7%0.003.8%
Usd Total Gains Per Share0.00-13.3%0.00-13.3%0.0128.0%0.003.2%0.003.2%
Usd Price Per Share0.03-0.03-0.02-0.03-0.04-
Price to Earnings Ratio-9.98--9.98--6.72--13.69--18.14-
Price-to-Total Gains Ratio-10.04--10.04-3.26--5.92--14.69-
Price to Book Ratio-140.51--140.51-7.39--12.44-1.91-
Price-to-Total Gains Ratio-10.04--10.04-3.26--5.92--14.69-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0127015
Number of shares78730
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (78730 shares)-199.2948.41
Gains per Year (78730 shares)-797.17193.64
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-797-807459-265184
20-1594-1604918-530378
30-2392-24011376-796572
40-3189-31981835-1061766
50-3986-39952294-1326960
60-4783-47922753-15911154
70-5580-55893212-18561348
80-6377-63863671-21221542
90-7175-71834129-23871736
100-7972-79804588-26521930

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.023.02.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%4.06.00.040.0%10.015.00.040.0%
Dividend per Share0.00.01.00.0%1.00.02.033.3%2.00.03.040.0%2.00.08.020.0%2.00.023.08.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%4.06.00.040.0%10.015.00.040.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Biotron Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.004-0.0040%0.002-264%-0.001-67%0.000-95%
Book Value Per Share--0.0000.0000%0.004-108%0.003-108%0.003-108%
Current Ratio--0.5790.5790%4.218-86%5.154-89%6.741-91%
Debt To Asset Ratio--1.4951.4950%0.233+542%0.474+215%0.315+374%
Debt To Equity Ratio----0%0.303-100%0.258-100%0.229-100%
Dividend Per Share----0%0.006-100%0.002-100%0.001-100%
Eps---0.004-0.0040%-0.004+2%-0.004-4%-0.003-17%
Free Cash Flow Per Share---0.004-0.0040%-0.004-8%-0.003-12%-0.003-22%
Free Cash Flow To Equity Per Share---0.004-0.0040%0.002-260%-0.001-70%0.000-96%
Gross Profit Margin--1.0001.0000%1.266-21%1.224-18%1.331-25%
Intrinsic Value_10Y_max---0.029--------
Intrinsic Value_10Y_min---0.042--------
Intrinsic Value_1Y_max---0.003--------
Intrinsic Value_1Y_min---0.004--------
Intrinsic Value_3Y_max---0.009--------
Intrinsic Value_3Y_min---0.012--------
Intrinsic Value_5Y_max---0.015--------
Intrinsic Value_5Y_min---0.020--------
Market Cap17143870.848-100%34287741.69634287741.6960%23460033.792+46%44393602.406-23%48354738.881-29%
Net Profit Margin----0%-2.4400%-2.1730%-1.8780%
Operating Margin----0%-3.5200%-2.6600%-2.4970%
Operating Ratio----0%3.520-100%2.660-100%2.771-100%
Pb Ratio-70.253+50%-140.505-140.5050%7.394-2000%-12.435-91%1.914-7440%
Pe Ratio-4.989+50%-9.977-9.9770%-6.717-33%-13.687+37%-18.138+82%
Price Per Share0.019-100%0.0380.0380%0.026+46%0.049-23%0.054-29%
Price To Free Cash Flow Ratio-4.804+50%-9.608-9.6080%-7.131-26%-14.685+53%-18.677+94%
Price To Total Gains Ratio-5.018+50%-10.035-10.0350%3.265-407%-5.922-41%-14.691+46%
Quick Ratio--0.5580.5580%4.193-87%5.103-89%6.667-92%
Return On Assets---6.964-6.9640%-0.845-88%-2.093-70%-1.468-79%
Return On Equity----0%-1.1010%-0.9970%-1.0290%
Total Gains Per Share---0.004-0.0040%0.008-148%0.001-512%0.001-517%
Usd Book Value---163135.392-163135.3920%2120920.536-108%1986397.211-108%2025400.777-108%
Usd Book Value Change Per Share---0.003-0.0030%0.002-264%-0.001-67%0.000-95%
Usd Book Value Per Share--0.0000.0000%0.002-108%0.002-108%0.002-108%
Usd Dividend Per Share----0%0.004-100%0.001-100%0.001-100%
Usd Eps---0.003-0.0030%-0.003+2%-0.002-4%-0.002-17%
Usd Free Cash Flow---2385589.045-2385589.0450%-2199388.398-8%-2111095.592-12%-1859432.215-22%
Usd Free Cash Flow Per Share---0.003-0.0030%-0.002-8%-0.002-12%-0.002-22%
Usd Free Cash Flow To Equity Per Share---0.003-0.0030%0.002-260%-0.001-70%0.000-96%
Usd Market Cap11460677.662-100%22921355.32422921355.3240%15683032.590+46%29677123.209-23%32325142.942-29%
Usd Price Per Share0.013-100%0.0250.0250%0.017+46%0.033-23%0.036-29%
Usd Profit---2297316.294-2297316.2940%-2334914.071+2%-2203466.782-4%-1905696.426-17%
Usd Revenue----0%956812.686-100%702563.952-100%857693.789-100%
Usd Total Gains Per Share---0.003-0.0030%0.005-148%0.001-512%0.001-517%
 EOD+2 -6MRQTTM+0 -0YOY+11 -225Y+4 -2910Y+5 -28

3.3 Fundamental Score

Let's check the fundamental score of Biotron Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.989
Price to Book Ratio (EOD)Between0-1-70.253
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.558
Current Ratio (MRQ)Greater than10.579
Debt to Asset Ratio (MRQ)Less than11.495
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-6.964
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Biotron Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.119
Ma 20Greater thanMa 500.021
Ma 50Greater thanMa 1000.021
Ma 100Greater thanMa 2000.027
OpenGreater thanClose0.020
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Biotron Ltd

Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. Biotron Limited was incorporated in 1999 and is based in Sydney, Australia.

Fundamental data was last updated by Penke on 2024-10-26 12:18:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Biotron earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Biotron to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biotron Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-244.0%+244.0%
TTM-5Y-217.3%+217.3%
5Y-217.3%10Y-187.8%-29.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--135.3%+135.3%
TTM--204.4%+204.4%
YOY-244.0%-207.5%-36.5%
5Y-217.3%-353.2%+135.9%
10Y-187.8%-464.5%+276.7%
4.3.1.2. Return on Assets

Shows how efficient Biotron is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biotron to the Biotechnology industry mean.
  • -696.4% Return on Assets means that Biotron generated $-6.96 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biotron Ltd:

  • The MRQ is -696.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -696.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-696.4%TTM-696.4%0.0%
TTM-696.4%YOY-84.5%-611.9%
TTM-696.4%5Y-209.3%-487.1%
5Y-209.3%10Y-146.8%-62.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-696.4%-10.7%-685.7%
TTM-696.4%-11.8%-684.6%
YOY-84.5%-11.0%-73.5%
5Y-209.3%-12.6%-196.7%
10Y-146.8%-14.3%-132.5%
4.3.1.3. Return on Equity

Shows how efficient Biotron is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biotron to the Biotechnology industry mean.
  • 0.0% Return on Equity means Biotron generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biotron Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-110.1%+110.1%
TTM-5Y-99.7%+99.7%
5Y-99.7%10Y-102.9%+3.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--13.5%+13.5%
TTM--15.9%+15.9%
YOY-110.1%-13.5%-96.6%
5Y-99.7%-18.5%-81.2%
10Y-102.9%-19.0%-83.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Biotron Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Biotron is operating .

  • Measures how much profit Biotron makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biotron to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biotron Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-352.0%+352.0%
TTM-5Y-266.0%+266.0%
5Y-266.0%10Y-249.7%-16.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--277.1%+277.1%
TTM--312.4%+312.4%
YOY-352.0%-223.5%-128.5%
5Y-266.0%-384.9%+118.9%
10Y-249.7%-494.6%+244.9%
4.3.2.2. Operating Ratio

Measures how efficient Biotron is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Biotron Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY3.520-3.520
TTM-5Y2.660-2.660
5Y2.66010Y2.771-0.111
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.842-2.842
TTM-3.179-3.179
YOY3.5203.301+0.219
5Y2.6604.794-2.134
10Y2.7716.520-3.749
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Biotron Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Biotron is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.58 means the company has $0.58 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Biotron Ltd:

  • The MRQ is 0.579. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.579. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.579TTM0.5790.000
TTM0.579YOY4.218-3.639
TTM0.5795Y5.154-4.575
5Y5.15410Y6.741-1.587
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5793.783-3.204
TTM0.5793.923-3.344
YOY4.2184.715-0.497
5Y5.1545.960-0.806
10Y6.7416.285+0.456
4.4.3.2. Quick Ratio

Measures if Biotron is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biotron to the Biotechnology industry mean.
  • A Quick Ratio of 0.56 means the company can pay off $0.56 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biotron Ltd:

  • The MRQ is 0.558. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.558. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.558TTM0.5580.000
TTM0.558YOY4.193-3.635
TTM0.5585Y5.103-4.545
5Y5.10310Y6.667-1.564
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5583.349-2.791
TTM0.5583.522-2.964
YOY4.1934.691-0.498
5Y5.1035.927-0.824
10Y6.6676.469+0.198
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Biotron Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Biotron assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biotron to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.49 means that Biotron assets are financed with 149.5% credit (debt) and the remaining percentage (100% - 149.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Biotron Ltd:

  • The MRQ is 1.495. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.495. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.495TTM1.4950.000
TTM1.495YOY0.233+1.262
TTM1.4955Y0.474+1.020
5Y0.47410Y0.315+0.159
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4950.338+1.157
TTM1.4950.347+1.148
YOY0.2330.309-0.076
5Y0.4740.365+0.109
10Y0.3150.380-0.065
4.5.4.2. Debt to Equity Ratio

Measures if Biotron is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biotron to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biotron Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY0.303-0.303
TTM-5Y0.258-0.258
5Y0.25810Y0.229+0.030
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.389-0.389
TTM-0.437-0.437
YOY0.3030.375-0.072
5Y0.2580.450-0.192
10Y0.2290.488-0.259
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Biotron generates.

  • Above 15 is considered overpriced but always compare Biotron to the Biotechnology industry mean.
  • A PE ratio of -9.98 means the investor is paying $-9.98 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biotron Ltd:

  • The EOD is -4.989. Based on the earnings, the company is expensive. -2
  • The MRQ is -9.977. Based on the earnings, the company is expensive. -2
  • The TTM is -9.977. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.989MRQ-9.977+4.989
MRQ-9.977TTM-9.9770.000
TTM-9.977YOY-6.717-3.261
TTM-9.9775Y-13.687+3.709
5Y-13.68710Y-18.138+4.451
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.989-2.431-2.558
MRQ-9.977-2.454-7.523
TTM-9.977-2.994-6.983
YOY-6.717-3.435-3.282
5Y-13.687-6.005-7.682
10Y-18.138-6.275-11.863
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biotron Ltd:

  • The EOD is -4.804. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -9.608. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -9.608. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.804MRQ-9.608+4.804
MRQ-9.608TTM-9.6080.000
TTM-9.608YOY-7.131-2.478
TTM-9.6085Y-14.685+5.076
5Y-14.68510Y-18.677+3.992
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.804-3.231-1.573
MRQ-9.608-3.234-6.374
TTM-9.608-3.528-6.080
YOY-7.131-4.567-2.564
5Y-14.685-8.099-6.586
10Y-18.677-8.945-9.732
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Biotron is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -140.51 means the investor is paying $-140.51 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Biotron Ltd:

  • The EOD is -70.253. Based on the equity, the company is expensive. -2
  • The MRQ is -140.505. Based on the equity, the company is expensive. -2
  • The TTM is -140.505. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-70.253MRQ-140.505+70.253
MRQ-140.505TTM-140.5050.000
TTM-140.505YOY7.394-147.900
TTM-140.5055Y-12.435-128.070
5Y-12.43510Y1.914-14.349
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-70.2531.938-72.191
MRQ-140.5051.983-142.488
TTM-140.5052.193-142.698
YOY7.3942.392+5.002
5Y-12.4353.608-16.043
10Y1.9144.220-2.306
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Biotron Ltd.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-06-302021-06-302022-06-302023-06-302024-06-30
Total Stockholder Equity 6,973-3,1103,863-2,7701,0922,0803,173-3,417-244
Net Working Capital  6,878-3,0683,810-2,7991,0122,0643,076-3,386-311
Gross Profit  7536621,415991,513-1251,388-1,428-40



5.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. All numbers in thousands.

Summary
Total Assets493
Total Liabilities738
Total Stockholder Equity-244
 As reported
Total Liabilities 738
Total Stockholder Equity+ -244
Total Assets = 493

Assets

Total Assets493
Total Current Assets427
Long-term Assets67
Total Current Assets
Cash And Cash Equivalents 393
Net Receivables 18
Other Current Assets 15
Total Current Assets  (as reported)427
Total Current Assets  (calculated)427
+/-0
Long-term Assets
Property Plant Equipment 13
Long-term Assets  (as reported)67
Long-term Assets  (calculated)13
+/- 54

Liabilities & Shareholders' Equity

Total Current Liabilities738
Long-term Liabilities0
Total Stockholder Equity-244
Total Current Liabilities
Short-term Debt 7
Accounts payable 286
Other Current Liabilities 445
Total Current Liabilities  (as reported)738
Total Current Liabilities  (calculated)738
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock56,915
Retained Earnings -58,681
Accumulated Other Comprehensive Income 1,522
Total Stockholder Equity (as reported)-244
Total Stockholder Equity (calculated)-244
+/-0
Other
Cash and Short Term Investments 393
Common Stock Shares Outstanding 902,170
Liabilities and Stockholders Equity 493
Net Debt -386
Net Working Capital -311
Short Long Term Debt Total 7



5.3. Balance Sheets Structured

All numbers in thousands.

 Trend2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-30
> Total Assets 
42,221
10,192
8,633
5,909
3,109
2,429
4,814
1,519
2,267
1,064
1,858
2,645
8,462
4,866
1,864
4,616
3,483
2,060
1,619
5,857
7,826
4,327
1,906
4,135
493
4934,1351,9064,3277,8265,8571,6192,0603,4834,6161,8644,8668,4622,6451,8581,0642,2671,5194,8142,4293,1095,9098,63310,19242,221
   > Total Current Assets 
11,021
9,924
8,110
5,518
2,748
2,204
4,669
1,426
2,152
996
1,814
2,613
8,439
4,843
1,799
4,568
3,446
2,030
1,601
5,777
7,719
4,262
1,762
4,031
427
4274,0311,7624,2627,7195,7771,6012,0303,4464,5681,7994,8438,4392,6131,8149962,1521,4264,6692,2042,7485,5188,1109,92411,021
       Cash And Cash Equivalents 
11,021
9,713
7,578
5,375
2,618
2,113
4,624
1,379
2,064
951
1,781
2,145
7,892
4,792
1,764
4,523
3,418
1,987
1,543
5,740
7,661
4,211
1,741
3,984
393
3933,9841,7414,2117,6615,7401,5431,9873,4184,5231,7644,7927,8922,1451,7819512,0641,3794,6242,1132,6185,3757,5789,71311,021
       Short-term Investments 
0
100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000001000
       Net Receivables 
0
111
413
67
66
46
5
41
59
28
9
453
504
2
0
10
0
0
0
0
0
0
0
23
18
182300000001002504453928594154666674131110
       Other Current Assets 
0
-100
30
10
0
7
19
6
25
15
15
15
15
15
35
45
28
43
58
37
58
51
21
24
15
1524215158375843284535151515151525619701030-1000
   > Long-term Assets 
31,200
268
522
391
362
224
145
93
115
67
44
32
23
24
65
48
37
29
18
46
107
65
144
104
67
671041446510746182937486524233244671159314522436239152226831,200
       Property Plant Equipment 
0
268
522
391
362
224
143
93
115
67
44
32
23
24
65
48
37
29
18
46
73
31
90
50
13
13509031734618293748652423324467115931432243623915222680
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
34
34
0
0
0
0
000034340000000000000000000
       Intangible Assets 
31,200
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000031,200
       Other Assets 
0
0
0
0
0
0
2
0
0
0
0
0
0
0
0
0
0
0
0
34
34
0
0
0
0
000034340000000000002000000
> Total Liabilities 
22
111
143
148
153
150
318
163
424
222
140
244
192
391
475
473
346
620
338
418
853
464
814
962
738
73896281446485341833862034647347539119224414022242416331815015314814311122
   > Total Current Liabilities 
22
111
143
148
153
150
318
163
424
222
140
244
192
391
475
473
346
620
338
412
841
451
751
956
738
73895675145184141233862034647347539119224414022242416331815015314814311122
       Short-term Debt 
0
100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
41
41
6
34
39
7
7393464141000000000000000001000
       Accounts payable 
0
111
138
133
0
0
0
0
227
35
32
89
28
174
267
249
92
344
136
158
310
138
311
285
286
286285311138310158136344922492671742889323522700001331381110
       Other Current Liabilities 
22
-100
5
15
153
150
318
163
197
187
108
156
164
217
208
224
254
275
202
254
490
307
405
632
445
445632405307490254202275254224208217164156108187197163318150153155-10022
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6
12
12
63
7
0
0763121260000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
0
43
7
0
07430300000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6
9
12
20
0
0
002012960000000000000000000
> Total Stockholder Equity
42,221
10,081
8,490
5,761
2,956
2,279
4,496
1,356
1,843
842
1,718
2,400
8,270
4,475
1,389
4,143
3,137
1,440
1,282
5,439
6,973
3,863
1,092
3,173
-244
-2443,1731,0923,8636,9735,4391,2821,4403,1374,1431,3894,4758,2702,4001,7188421,8431,3564,4962,2792,9565,7618,49010,08142,221
   Common Stock
11,163
11,417
11,445
11,445
11,445
12,651
16,865
16,865
19,146
19,921
20,751
23,088
32,549
32,549
32,549
37,208
39,163
40,325
41,439
47,523
52,844
52,844
52,844
56,890
56,915
56,91556,89052,84452,84452,84447,52341,43940,32539,16337,20832,54932,54932,54923,08820,75119,92119,14616,86516,86512,65111,44511,44511,44511,41711,163
   Retained Earnings -58,681-55,264-51,837-49,087-45,945-42,369-40,757-39,164-36,887-34,405-31,681-28,596-24,745-22,859-21,311-19,439-17,663-15,806-12,620-10,483-8,600-5,795-3,065-1,422-142
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
285
0
0
0
1,527
0
01,5270002850000000000000000000
   Treasury Stock0000000000000000000000000
   Other Stockholders Equity 
31,200
0
0
0
0
0
0
0
0
0
0
0
0
0
522
522
43
74
85
285
-6,899
-3,757
-1,007
-1,627
0
0-1,627-1,007-3,757-6,899285857443522522000000000000031,200



5.4. Balance Sheets

All numbers in thousands.




5.5. Cash Flows

All numbers in thousands.